Počet záznamů: 1  

Exosomal transfer of miR-126 promotes the anti-tumour response in malignant mesothelioma: Role of miR-126 in cancer-stroma communication

  1. 1.
    SYSNO ASEP0521316
    Druh ASEPJ - Článek v odborném periodiku
    Zařazení RIVJ - Článek v odborném periodiku
    Poddruh JČlánek ve WOS
    NázevExosomal transfer of miR-126 promotes the anti-tumour response in malignant mesothelioma: Role of miR-126 in cancer-stroma communication
    Tvůrce(i) Monaco, F. (IT)
    Gaetani, S. (IT)
    Alessandrini, F. (IT)
    Tagliabracci, A. (IT)
    Bracci, M. (IT)
    Valentino, M. (IT)
    Neužil, Jiří (BTO-N) RID
    Amati, M. (IT)
    Bovenzi, M. (IT)
    Tomasetti, M. (IT)
    Santarelli, L. (IT)
    Celkový počet autorů11
    Zdroj.dok.Cancer letters. - : Elsevier - ISSN 0304-3835
    Roč. 463, č. 2019 (2019), s. 27-36
    Poč.str.10 s.
    Jazyk dok.eng - angličtina
    Země vyd.NL - Nizozemsko
    Klíč. slovapleural mesothelioma ; angiogenesis ; cells ; repression ; apoptosis
    Vědní obor RIVFD - Onkologie a hematologie
    Obor OECDOncology
    CEPNV16-31604A GA MZd - Ministerstvo zdravotnictví
    Způsob publikováníOpen access
    Institucionální podporaBTO-N - RVO:86652036
    UT WOS000486135000003
    DOI10.1016/j.canlet.2019.08.001
    AnotaceMiR-126 has been shown to suppress malignant mesothelioma (MM) by targeting cancer-related genes without inducing toxicity or histopathological changes. Exosomes provide the opportunity to deliver therapeutic cargo to cancer stroma. Here, a tumour stromal model composed of endothelial cells (HUVECs), fibroblasts (IMR-90 cells), non-malignant mesothelial cells (Met-5A cells) and MM cells (H28 and MM-B1 cells) was used. The cells were treated with exosomes from HUVECs carrying endogenous (exo-HUVEC) and enriched miR-126 (exo-HUVECmiR-126), and the uptake/turnover of exosomes, miR-126 distribution within the stroma, and effect of miR-126 on cell signalling, angiogenesis and cell proliferation were evaluated. Based on the sensitivity of MM cells to exo-HUVEC miR-126 treatment, miR-126 was distributed differently across stromal cells. The reduced miR-126 content in fibroblasts in favour of endothelial cells reduced angiogenesis and suppressed cell growth in an miR-126-sensitive environment. Conversely, the accumulation of miR-126 in fibroblasts and the reduced level of miR-126 in endothelial cells induced tube formation in an miR-126-resistant environment via VEGF/EGFL7 upregulation and IRS1-mediated cell proliferation. These findings suggest that transfer of miR-126 via HUVEC-derived exosomes represents a novel strategy to inhibit angiogenesis and cell growth in MM.
    PracovištěBiotechnologický ústav
    KontaktMonika Kopřivová, Monika.Koprivova@ibt.cas.cz, Tel.: 325 873 700
    Rok sběru2020
    Elektronická adresahttps://www.sciencedirect.com/science/article/abs/pii/S0304383519304240?via%3Dihub
Počet záznamů: 1  

  Tyto stránky využívají soubory cookies, které usnadňují jejich prohlížení. Další informace o tom jak používáme cookies.